Risk-adjusted hazard analysis of survival after pulmonary metastasectomy for uterine malignancies in 319 casesCentral MessagePerspective by Yuya Nobori, MD, Masaki Anraku, MD, Yoshikane Yamauchi, MD, Mingyon Mun, MD, Ichiro Yoshino, MD, Jun Nakajima, MD, PhD, Norihiko Ikeda, MD, Haruhisa Matsuguma, MD, Takekazu Iwata, MD, Yasushi Shintani, MD, Mitsuo Nakayama, MD, Takahiko Oyama, MD, Masayuki Chida, MD, Hiroaki Kuroda, MD, Hiroshi Hashimoto, MD, Yoko Azuma, MD, Kazuhito Funai, MD, Makoto Endoh, MD, Yukari Uemura, PhD, Masafumi Kawamura, MD

Get full text

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC by Akira Hamada, MD, Kenichi Suda, MD, PhD, Toshio Fujino, MD, PhD, Masaya Nishino, MD, PhD, Shuta Ohara, MD, PhD, Takamasa Koga, MD, PhD, Takanobu Kabasawa, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Makoto Endoh, MD, PhD, Toshiki Takemoto, MD, PhD, Junichi Soh, MD, PhD, Naoki Yanagawa, MD, PhD, Satoshi Shiono, MD, PhD, Tetsuya Mitsudomi, MD, PhD

Get full text